| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.952 | 7.354 | 8.777 | 15.627 | 28.091 | 87.661 | 120.114 |
| Total Income - EUR | - | - | - | 3.952 | 7.356 | 8.818 | 15.631 | 28.092 | 87.674 | 120.132 |
| Total Expenses - EUR | - | - | - | 135 | 176 | 180 | 2.407 | 5.200 | 12.645 | 25.270 |
| Gross Profit/Loss - EUR | - | - | - | 3.817 | 7.179 | 8.638 | 13.224 | 22.892 | 75.029 | 94.863 |
| Net Profit/Loss - EUR | - | - | - | 3.699 | 6.959 | 8.391 | 12.765 | 22.452 | 74.170 | 91.511 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oncoharmony S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 6 | 0 | 0 | 0 | 0 | 0 | 39.096 |
| Current Assets | - | - | - | 3.929 | 7.101 | 8.605 | 13.284 | 23.727 | 75.296 | 88.111 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 806 | 919 | 6.043 | 9.309 | 15.040 | 39.342 | 64.880 |
| Cash | - | - | - | 3.123 | 6.182 | 2.561 | 3.975 | 8.687 | 35.954 | 23.231 |
| Shareholders Funds | - | - | - | 3.741 | 7.009 | 8.440 | 12.813 | 22.501 | 74.218 | 91.560 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 193 | 92 | 165 | 471 | 1.226 | 1.078 | 35.648 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncoharmony S.r.l.